Ventana Biotech Stock Market Value
| VNTA Stock | USD 0.02 0 10.79% |
| Symbol | Ventana |
Ventana Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Ventana Biotech's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Ventana Biotech.
| 04/25/2025 |
| 07/24/2025 |
If you would invest 0.00 in Ventana Biotech on April 25, 2025 and sell it all today you would earn a total of 0.00 from holding Ventana Biotech or generate 0.0% return on investment in Ventana Biotech over 90 days. Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners comm... More
Ventana Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Ventana Biotech's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Ventana Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 86.23 |
Ventana Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Ventana Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Ventana Biotech's standard deviation. In reality, there are many statistical measures that can use Ventana Biotech historical prices to predict the future Ventana Biotech's volatility.| Risk Adjusted Performance | 0.0219 | |||
| Jensen Alpha | 0.4401 | |||
| Total Risk Alpha | (2.06) | |||
| Treynor Ratio | (0.08) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Ventana Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Ventana Biotech Backtested Returns
Ventana Biotech appears to be out of control, given 3 months investment horizon. Ventana Biotech owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0697, which indicates the firm had a 0.0697 % return per unit of risk over the last 3 months. By inspecting Ventana Biotech's technical indicators, you can evaluate if the expected return of 0.62% is justified by implied risk. Please review Ventana Biotech's Coefficient Of Variation of 6935.15, variance of 89.53, and Risk Adjusted Performance of 0.0219 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Ventana Biotech holds a performance score of 5. The entity has a beta of -1.52, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Ventana Biotech are expected to decrease by larger amounts. On the other hand, during market turmoil, Ventana Biotech is expected to outperform it. Please check Ventana Biotech's jensen alpha, daily balance of power, as well as the relationship between the Daily Balance Of Power and price action indicator , to make a quick decision on whether Ventana Biotech's existing price patterns will revert.
Auto-correlation | -0.19 |
Insignificant reverse predictability
Ventana Biotech has insignificant reverse predictability. Overlapping area represents the amount of predictability between Ventana Biotech time series from 25th of April 2025 to 9th of June 2025 and 9th of June 2025 to 24th of July 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Ventana Biotech price movement. The serial correlation of -0.19 indicates that over 19.0% of current Ventana Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.19 | |
| Spearman Rank Test | 0.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Ventana Biotech lagged returns against current returns
Autocorrelation, which is Ventana Biotech pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Ventana Biotech's pink sheet expected returns. We can calculate the autocorrelation of Ventana Biotech returns to help us make a trade decision. For example, suppose you find that Ventana Biotech has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Ventana Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Ventana Biotech pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Ventana Biotech pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Ventana Biotech pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Ventana Biotech Lagged Returns
When evaluating Ventana Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Ventana Biotech pink sheet have on its future price. Ventana Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Ventana Biotech autocorrelation shows the relationship between Ventana Biotech pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Ventana Biotech.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VALE | Vale SA ADR | |
| EGY | Vaalco Energy | |
| CMCSA | Comcast Corp |
Other Information on Investing in Ventana Pink Sheet
Ventana Biotech financial ratios help investors to determine whether Ventana Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ventana with respect to the benefits of owning Ventana Biotech security.